Overview

The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1

Status:
Unknown status

Trial end date:
2017-02-01

Target enrollment:
0

Participant gender:
All

Summary

Nocturnal hypertension is recognized via ambulatory blood pressure monitoring in adolescents with type 1 diabetes mellitus. Melatonin, (as previously seen in earlier studies in adults), may alter these changes, which may be a benefit especially for patients with diabetes mellitus who are at risk for cardiovascular changes. The purpose of this study is to estimate the use of melatonin as treatment for nocturnal hypertension in young adults with type 1 diabetes melitus.

Phase:

Early Phase 1

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Sheba Medical Center

Treatments:

Melatonin

Criteria

Inclusion Criteria:

- Teenagers and young adults with type 1 diabetes mellitus for at least two years

Exclusion Criteria:

- Previously known cardiovascular or renal disease

- Any previously use of antihypertensive drugs